Use Of Fragmin In Hemodialysis
A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 152 participants.
Also called NCT01879618
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 152 participants
- Sponsor
- Registry
-
NCT01879618
-
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- Canada
- Registry status
- Completed
Technical summary
Registry record NCT01879618. Allocation not applicable; no masking; primary purpose treatment. Start 2013-10 (registry gives no type); primary completion 2016-03 (actual). Results posted on 2016-12-29.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Use Of Fragmin In Hemodialysis
- Condition
- Chronic Renal Failure
- Intervention (Drug)
- Fragmin
- Lead sponsor
- Pfizer
Record details
- Record id
cardio:ct-nct01879618- Content hash
c586f0d0ff19652cac1411eec2026f5cf3379393db12f784e434413ab0d85a07